NCT00360087View on ClinicalTrials.gov

A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study

PHASE3TerminatedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

December 31, 2007

Conditions
Pulmonary HypertensionSickle Cell Anemia
Interventions
DRUG

Bosentan

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Actelion

INDUSTRY